Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aevi Genomic Medicine Logo
Aevi Genomic Medicine CB Rank
256156
Heat Score
22
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies.
Acquired by
Cerecor Logo
Cerecor
Founded
obfuscation
PublicPost-IPO Equity Wayne, Pennsylvania, United States11-50 aevigenomics.com/
Biopharma
Biotechnology
Health Care
Life Science
Overview

Aevi Genomic Medicine
Total Funding
obfuscation
Heat Score
22

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 22
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Aevi Genomic Medicine

CB Rank
256156
Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies.
Acquired by
Cerecor Logo
Cerecor
Founded
obfuscation
PublicPost-IPO Equity Wayne, Pennsylvania, United States11-50 aevigenomics.com/
Biopharma
Biotechnology
Health Care
Life Science

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Aevi Genomic Medicine, Inc.
Also Known As Medgenics
Operating Status Closed
Stock Symbol  NASDAQ:GNMX
Company Type For Profit
Founders  Andrew Pearlman
About the Company

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies.

Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an

internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.

Phone Number 1-610-254-4201
Contact Email Mary.Scavello@aevigenomics.com
Predictions & Insights

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 9
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Aevi Genomic Medicine Logo
Post-IPO Equity - Aevi Genomic Medicine
—
obfuscation
— Post-IPO Equity

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1

M&A Details

Aevi Genomic Medicine was acquired by Cerecor for
obfuscation
on
obfuscation
. This deal was done in Stock.
Transaction Name 
Aevi Genomic Medicine acquired by Cerecor Logo
Aevi Genomic Medicine acquired by Cerecor
Acquired by 
Cerecor Logo
Cerecor
Announced Date 
obfuscation
Price 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News

News and Press

News•Jul 19, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 13, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 9, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Actively Used Products

5Aevi Genomic Medicine uses 5 technology products and services including HTML5, Google Analytics, and  Office 365, according to G2 Stack.

Active Website Tech Count

7Aevi Genomic Medicine is actively using 7 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, IPv6, and  Microsoft.

Total IP

5The intellectual property of Aevi Genomic Medicine includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Aevi Genomic Medicine has registered 2 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Aevi Genomic Medicine's headquarters? Aevi Genomic Medicine is located in Wayne, Pennsylvania, United States.Who invested in Aevi Genomic Medicine? Aevi Genomic Medicine has 4 investors including The Children's Hospital of Philadelphia and  Alta Partners.When was the last funding round for Aevi Genomic Medicine? Aevi Genomic Medicine closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Aevi Genomic Medicine raised to date? Aevi Genomic Medicine has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|